IT GOES DEEPER · THE ARCHIVE · MONEY & POWER · CASE 6423-06

Big Pharma

FILE DATE 1980
CROSS-REFS 04
STATUS NEVER CLOSED
SUMMARY
The suspicion industrial: real, documented scandals (opioid settlements, buried studies) feeding an undocumented folklore of cures withheld. The confirmed receipts keep the unconfirmed legends funded.
FULL DOSSIER
Big Pharma: the claim that drug companies suppress cures to sell treatments. Documented substrate: real convictions and settlements at industrial scale — GSK ($3B, 2012), Purdue's guilty pleas over OxyContin marketing, documented trial-data suppression (Study 329) — and the insulin pricing record. Documented counterweight: cures do ship (HCV cured by Sovaldi, profitably), and suppressing one would require silencing global competitors, regulators, and academics with opposite incentives. The lore takes true corporate malfeasance and extends it past the point where the incentive analysis breaks.
SOURCES ON RECORD
01United States v. GlaxoSmithKline settlement (2012)
02Purdue guilty pleas (2007; 2020)
03Keller et al. Study 329 + Le Noury reanalysis, BMJ (2015)
04Goldacre, Bad Pharma (2012)
CROSS-REFERENCED FILES
THE RETRACTED PAPERPSYCHEDELIC RENAISSANCETHE FLUORIDE QUESTIONMKULTRA
◉ OPEN THIS FILE ON THE GLOBE
ENTRIES ARE CLAIMS, CASES & LEGENDS — NOT ENDORSEMENTS. VERIFY AGAINST THE SOURCES ON RECORD. TRUST NO ONE, ESPECIALLY THIS FILE.
⚠ THE ARCHIVE IS A WORK IN PROGRESS — DOSSIERS ARE STILL BEING WRITTEN, EXPANDED & CORRECTED.